Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.
- NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.
- NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_assertion evidence source_evidence_literature NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.
- NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_assertion SIO_000772 14961035 NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.
- NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_assertion wasDerivedFrom befree-20140225 NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.
- NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_assertion wasGeneratedBy ECO_0000203 NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.